Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.25
Bid: 40.00
Ask: 40.50
Change: 0.25 (0.63%)
Spread: 0.50 (1.25%)
Open: 40.00
High: 40.50
Low: 39.75
Prev. Close: 40.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

Wed, 14th Jul 2021 11:30

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Symphony Environmental Technologies, up 11% at 21.17 pence, 12-month range 10.65p-47.0p. The anti-microbial plastic technologies firm receives approval from the US Food & Drug Administration for its d2p antimicrobial food contact technology.

----------

88 Energy, up 7.9% at 1.89p, 12-month range 0.24p-4.70p. The Alaska-focused oil exploration and appraisal company says additional phase one geochemical analysis of fluid extracts from Merlin-1 well core samples again demonstrates the presence of hydrocarbons. Results from phase two of side-wall core trim analysis are expected in the next few weeks. Phase two is designed to confirm not only the presence of oil but also the nature of the source rock, to help understand the likely quality of the oil as well as migration pathways.

----------

Alpha FX Group, up 6.7% at 1,665.00p, 12-month range 677p-1,720p. The foreign exchange risk management and international payments firm says trading in the first half ended June 30 has been "strong" across its business, with revenue up 89% year on year at GBP34 million. Adds 84 new clients and notes average revenue per client continued to increase. The company expects to exceed current internal expectations for 2021, on the back of continued strong trading. In 2020, saw revenue of GBP46.2 million with pretax profit of GBP17.1 million.

----------

Avacta, up 5.9% at 143.56p, 12-month range 88.66p-291.80p. The developer of diagnostics and cancer therapies says Life Sciences unit gets ISO 13485 certification for the quality management system for the manufacture and distribution of Affimer reagents for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.

----------

Fulcrum Utility Services, up 5.6% at 32.74p, 12-month range 28.25p-43.60p. The energy and multi-utility services provider wins new GBP4.9 million multi-utility infrastructure contract from unnamed "large investor developer", for a "major" new employment park in the West Midlands. As part of the contract, the company will design and install a high voltage primary substation and the electricity, water, and gas infrastructure to "energise and power" the new development.

----------

AIM - LOSERS

----------

Tern, down 13% at 19.40p, 12-month range 5.50p-31.67p. The investment firm completes fundraise at the issue price of 18.8p per share. The retail offer and subscription were both oversubscribed and the company said it raised GBP2 million and GBP4 million, respectively. "We intend to utilise the proceeds to maximise the value to our shareholders of our portfolio, and I look forward to providing further updates in due course," says Chief Executive Al Sisto.

----------

Kromek Group, down 7.0% at 15.00p, 12-month range 7.66p-25.20p. The detection technology firm says revenue totalled GBP10.4 million for the financial year that ended April 30 versus GBP13.1 million the year before. Pretax loss, however, narrows to GBP6.3 million from GBP18.3 million loss the year prior. This is due to non-repeat of GBP13.1 million of exceptional impairment losses on trade receivables and amounts recoverable on contracts. Separately, Kromek says it wins new contracts and orders across all segments for delivery this year.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Oct 2015 15:02

Earnings, Trading Statements Calendar - Week Ahead

Read more
19 Oct 2015 06:53

Avacta Group Says Research Supports Affirmers Use In Crop Protection

Read more
9 Oct 2015 08:07

Avacta Says Collaborator Demonstrates Affimers With Luminex Platform

Read more
17 Sep 2015 07:00

Avacta Snaps Up GlaxoSmithKline Alumni As Non-Executive

Read more
15 Jul 2015 07:26

Avacta Raises GBP22 Million To Back Affirmers, IP Group Participates (ALLISS)

Read more
8 Jul 2015 13:46

CORRECT: UPDATE: Avacta Says Annual Revenue To Meet Expectations As CFO Departs

Read more
7 Jul 2015 08:56

UPDATE: Avacta Says Annual Revenue To Meet Expectations As CFO Departs

Read more
7 Jul 2015 08:46

PROACTIS Appoints Avacta's Tim Sykes As Chief Financial Officer

Read more
7 Jul 2015 08:37

Avacta Says Annual Revenue To Meet Expectations As CFO Steps Down

Read more
18 May 2015 15:31

Avacta Group surges on Moderna deal

Shares in Avacta Group surged over 25% on Monday, after the proprietary diagnostic tools provider said it had reached a deal with biotech group Moderna Therapeutics. The London-listed company said its Life Sciences division had entered a collaboration, licensing and option agreement with US-based Mo

Read more
18 May 2015 11:04

LONDON MIDDAY BRIEFING: BHP Billiton Hit As South32 Starts Trading

Read more
18 May 2015 10:40

WINNERS & LOSERS: BHP Billiton Down As South32 Share Price Disappoints

Read more
18 May 2015 08:35

BROKER RATINGS SUMMARY: Goldman Sachs Cuts BP To Sell From Neutral

Read more
18 May 2015 06:48

Avacta Group Signs Licensing And Option Deal With Moderna Therapeutics

Read more
28 Apr 2015 10:33

Avacta First-Half Loss Widens On Affimer Business Investment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.